|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Non-Qualified Stock Option (Right to Buy) | $ 1.17 | 02/18/2014 | M(1) | 1,667 | (5) | 02/25/2016 | Common Stock | 1,667 | $ 0 | 0 | D | ||||
Non-Qualified Stock Option (Right to Buy) | $ 7.5 | 02/18/2014 | M(1) | 3,443 | (6) | 09/03/2016 | Common Stock | 3,443 | $ 0 | 0 | D | ||||
Non-Qualified Stock Option (Right to Buy) | $ 13.08 | 02/18/2014 | M(1) | 12,500 | (7) | 11/17/2016 | Common Stock | 12,500 | $ 0 | 0 | D | ||||
Non-Qualified Stock Option (Right to Buy) | $ 11.37 | 02/18/2014 | M(1) | 795 | (8) | 11/15/2017 | Common Stock | 795 | $ 0 | 16,810 | D | ||||
Non-Qualified Stock Option (Right to Buy) | $ 11.37 | 02/19/2014 | M(1) | 560 | (9) | 11/15/2017 | Common Stock | 560 | $ 0 | 16,250 | D | ||||
Non-Qualified Stock Option (Right to Buy) | $ 15.85 | 02/19/2014 | M(1) | 3,333 | (10) | 03/12/2020 | Common Stock | 3,333 | $ 0 | 16,667 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Crawford Bruce A C/O NANOMETRICS, INC. 1550 BUCKEY DRIVE MILPITAS, CA 95035 |
Chief Operating Officer |
/s/ Ronald W. Kisling, Attorney-in-Fact | 02/19/2014 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Transaction pursuant to Rule 10b5-1 Plan adopted December 13, 2013. |
(2) | Represents weighted average sales price. The shares were sold at prices ranging from $18.45 to $18.84. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
(3) | Represents weighted average sales price. The shares were sold at prices ranging from $18.40 to $18.70. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
(4) | Represents weighted average sales price. The shares were sold at prices ranging from $18.28 to $18.58. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
(5) | One thirty-sixth (1/36th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (February 25, 2009). |
(6) | One third (1/3rd) of the shares are fully vested on the date of grant, with the remaining shares vesting (starting on the one year anniversary of the date of grant) at a rate of one twenty-fourth (1/24th) per month until fully vested on September 3, 2012. |
(7) | One thirty-sixth (1/36th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 17, 2009). |
(8) | One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 16, 2010). |
(9) | One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 16, 2010). |
(10) | One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (March 12, 2013). |